![Pierluigi Paracchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/06/2026
Pierluigi Paracchi was the founder of Xyence Capital SGR SpA, founded in 2003, where the title held was Chief Executive Officer from 2009 to 2011.
Mr. Paracchi is the founder of Genenta Science SpA, founded in 2014, holding the title of Chairman & Chief Executive Officer starting in 2024.
Mr. Paracchi is the founder of Aurora-TT Srl, founded in 2017, with the title of Venture Consultant starting in 2017.
Mr. Paracchi is also the founder of Aurora Science Srl..
Mr. Paracchi is Chairman & Chief Executive Officer at Praexidia Industrie Strategiche SpA starting in 2025.
Mr. Paracchi is Director at Assobiotec starting in 2019.
Mr. Paracchi is Director at Altheia Science Srl.
Former positions include Non-Executive Chairman at Lipogems International SpA, Director at EOS SpA, and Venture Partner at Axon Partners Group Investment SGEIC SA. Education includes undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENENTA SCIENCE SPA 12,64 % | 30/03/2026 | 2.302.516 ( 12,64 % ) | 4 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director Ejecutivo | 24/07/2014 |
Aurora-TT Srl
 Aurora-TT Srl Investment ManagersFinance Aurora-TT is an active manager which invests in Italian startups . The firm invests in pre-seed to early stage in the health technology sector with particular preference for biotechnology and pharmaceuticals. | Fundador | 01/01/2017 |
Altheia Science Srl
 Altheia Science Srl Pharmaceuticals: MajorHealth Technology Develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes | Director/Miembro de la Junta | - |
Assobiotec
 Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Director/Miembro de la Junta | 15/05/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Xyence Capital SGR SpA
 Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Fundador | 01/02/2011 |
Axon Partners Group Investment SGEIC SA
 Axon Partners Group Investment SGEIC SA Investment ManagersFinance Axon Partners Group invests in lower to middle market companies located in Spain, Italy, Latin America and Europe. The firm focuses on climate technology, infrastructure, B2B and B2C sectors. It provides financing in early, secondary and growth stage transactions. The firm also acquires minority interests. | Inversor de Capital Privado | - |
Lipogems International SpA
 Lipogems International SpA Medical SpecialtiesHealth Technology Manufactures and supplies medical devices | Presidente | - |
Aurora Science Srl
 Aurora Science Srl Investment ManagersFinance Functions as a venture capital fund | Fundador | - |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Università Cattolica del Sacro Cuore Campus di Milano
 Università Cattolica del Sacro Cuore Campus di Milano Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axon Partners Group Investment SGEIC SA
Axon Partners Group Investment SGEIC SA Investment ManagersFinance Axon Partners Group invests in lower to middle market companies located in Spain, Italy, Latin America and Europe. The firm focuses on climate technology, infrastructure, B2B and B2C sectors. It provides financing in early, secondary and growth stage transactions. The firm also acquires minority interests. | Finance |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Xyence Capital SGR SpA
Xyence Capital SGR SpA Investment ManagersFinance Xyence Capital invests in startup companies located in europe the United States and Italy. The firm targets companies operating in the field of electronic and health technology sector with particular focus in biotechnology and IT services. It provides equity for early to later stage as well as growth capital requirements with invests between EUR 0.5 to EUR 24 million. | Finance |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Commercial Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Lipogems International SpA
Lipogems International SpA Medical SpecialtiesHealth Technology Manufactures and supplies medical devices | Health Technology |
Altheia Science Srl
Altheia Science Srl Pharmaceuticals: MajorHealth Technology Develop treatment and resolving medicines for auto-immune diseases, focusing on multiple sclerosis and diabetes | Health Technology |
Aurora-TT Srl
Aurora-TT Srl Investment ManagersFinance Aurora-TT is an active manager which invests in Italian startups . The firm invests in pre-seed to early stage in the health technology sector with particular preference for biotechnology and pharmaceuticals. | Finance |
Aurora Science Srl
Aurora Science Srl Investment ManagersFinance Functions as a venture capital fund | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
